Toll Free: 1-888-928-9744
Published: Feb, 2016 | Pages:
34 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Integrated BioTherapeutics, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Integrated BioTherapeutics, Inc. - Product Pipeline Review - 2016', provides an overview of the Integrated BioTherapeutics, Inc.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Integrated BioTherapeutics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Integrated BioTherapeutics, Inc. - The report provides overview of Integrated BioTherapeutics, Inc. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Integrated BioTherapeutics, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Integrated BioTherapeutics, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to Buy - Evaluate Integrated BioTherapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Integrated BioTherapeutics, Inc. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Integrated BioTherapeutics, Inc.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Integrated BioTherapeutics, Inc. Snapshot 5 Integrated BioTherapeutics, Inc. Overview 5 Key Information 5 Key Facts 5 Integrated BioTherapeutics, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Integrated BioTherapeutics, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Combination Treatment Modalities 10 Integrated BioTherapeutics, Inc. - Pipeline Products Glance 11 Integrated BioTherapeutics, Inc. - Clinical Stage Pipeline Products 11 Phase I Products/Combination Treatment Modalities 11 Integrated BioTherapeutics, Inc. - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Discovery Products/Combination Treatment Modalities 13 Integrated BioTherapeutics, Inc. - Drug Profiles 14 STEBVax 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 (Ebola + Marburg) vaccine 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Antibodies for Ebola and Marburg Viral Infections 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 AT-62aa 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Monoclonal Antibodies for Ebola and Marburg Infections 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Monoclonal Antibodies for Equine Encephalitis and Chikungunya 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Monoclonal Antibodies to Inhibit E2 Glycoprotein for HCV 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Monoclonal Antibody 1 for Staphylococcus Aureus Infections 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Integrated BioTherapeutics, Inc. - Pipeline Analysis 26 Integrated BioTherapeutics, Inc. - Pipeline Products by Target 26 Integrated BioTherapeutics, Inc. - Pipeline Products by Route of Administration 27 Integrated BioTherapeutics, Inc. - Pipeline Products by Molecule Type 28 Integrated BioTherapeutics, Inc. - Pipeline Products by Mechanism of Action 29 Integrated BioTherapeutics, Inc. - Recent Pipeline Updates 30 Integrated BioTherapeutics, Inc. - Dormant Projects 31 Integrated BioTherapeutics, Inc. - Locations And Subsidiaries 32 Head Office 32 Appendix 33 Methodology 33 Coverage 33 Secondary Research 33 Primary Research 33 Expert Panel Validation 33 Contact Us 33 Disclaimer 34
List of Tables Integrated BioTherapeutics, Inc., Key Information 5 Integrated BioTherapeutics, Inc., Key Facts 5 Integrated BioTherapeutics, Inc. - Pipeline by Indication, 2016 7 Integrated BioTherapeutics, Inc. - Pipeline by Stage of Development, 2016 8 Integrated BioTherapeutics, Inc. - Monotherapy Products in Pipeline, 2016 9 Integrated BioTherapeutics, Inc. - Combination Treatment Modalities in Pipeline, 2016 10 Integrated BioTherapeutics, Inc. - Phase I, 2016 11 Integrated BioTherapeutics, Inc. - Preclinical, 2016 12 Integrated BioTherapeutics, Inc. - Discovery, 2016 13 Integrated BioTherapeutics, Inc. - Pipeline by Target, 2016 26 Integrated BioTherapeutics, Inc. - Pipeline by Route of Administration, 2016 27 Integrated BioTherapeutics, Inc. - Pipeline by Molecule Type, 2016 28 Integrated BioTherapeutics, Inc. - Pipeline Products by Mechanism of Action, 2016 29 Integrated BioTherapeutics, Inc. - Recent Pipeline Updates, 2016 30 Integrated BioTherapeutics, Inc. - Dormant Developmental Projects,2016 31
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.